[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415-417.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(06):415-417.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
点击复制

减重手术对多囊卵巢综合征的治疗作用()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年06期
页码:
415-417
栏目:
综述
出版日期:
2014-12-20

文章信息/Info

Title:
Therapeutic effects of bariatric surgery on polycystic ovary syndrome
作者:
曹琳; 杨昱; 刘超
210028 南京,中国中医科学院江苏分院; 南京中医药大学附属中西医结合医院内分泌与代谢病科
Author(s):
Cao Lin;  Yang Yu;  Liu Chao.
Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine,Jiangsu Branch of China Academy of Chinese Medical Science, Nanjing 210028, China
关键词:
多囊卵巢综合征;  代谢综合征;  减重手术;  肥胖;  不孕
Keywords:
Polycystic ovary syndrome;  Metabolic syndrome;  Bariatric surgery;  Obesity;  Infertility
DOI:
10.3760/cma.j.issn.1673-4157.2014.06.015
摘要:
多囊卵巢综合征(PCOS)是女性常见的内分泌疾病,PCOS容易合并肥胖和代谢综合征,但其代谢紊乱的危害容易被忽视。减重手术可以有效降低体重,恢复下丘脑-垂体轴正常功能,降低心血管风险、提高妊娠几率,预防或逆转代谢综合征。故减重手术可推荐作为PCOS女性尤其是合并代谢综合征患者的有效治疗手段。
Abstract:
Polycystic ovary syndrome(PCOS)is a common endocrine disorder in women.Obesity and metabolic syndrome(MS)usually coexist with PCOS, though their metabolic consequences are overlooked and undertreated in these patients. Bariatric surgery is efficient in achieving significant weight loss, restoring the normal function of hypothalamic pituitary axis, decreasing cardiovascular risk and improving pregnancy outcomes. It may prevent or reverse metabolic syndrome. Therefore bariatric surgery may be recommended for PCOS women, especially in those with MS.

参考文献/References:

[1] Flegal KM,Carroll MD,Ogden CL,et al.Prevalence and trends in obesity among US adults,1999-2008[J].JAMA,2010, 303(3): 235-241.
[2] McCullough AJ. Epidemiology of the metabolic syndrome in the USA[J]. J Dig Dis, 2011,12(5):333-340.
[3] Wadden TA,Volger S,Sarwer DB,et al. A two-year randomized trial of obesity treatment in primary care practice[J]. N Engl J Med, 2011, 365(21): 1969-1979.
[4] Colquitt JL,Picot J,Loveman E,et al. Surgery for obesity[J]. Cochrane Database Syst Rev,2009,(2): CD003641.
[5] Padwal R,Klarenbach S,Wiebe N,et al. Bariatric surgery: a systematic review of the clinical and economic evidence[J].J Gen Intern Med,2011,26: 1183-1194.
[6] Buchwald H,Estok R,Fahrbach K,et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis[J]. Am J Med,2009,122(3): 248-256.e5.
[7] Lima MM,Pareja JC,Alegre SM,et al. Acute effect of Roux-en-Y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab,2010,95(8): 3871-3875.
[8] Jankiewicz-Wika J,Koomecki K,Cywiński J,et al. Impact of vertical banded gastroplasty on body weight,insulin resistance,adipocytokine,inflammation and metabolic syndrome markers in morbidly obese patients[J].Endokrynol Pol,2011,62(2): 109-119.
[9] Woelnerhanssen B,Peterli R,Steinert RE,et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial[J]. Surg Obes Relat Dis,2011,7(5): 561-568.
[10] Buchwald H,Avidor Y,Braunwald E,et al. Bariatric surgery: a systematic review and meta-analysis[J].JAMA,2004,292(14): 1724-1737.
[11] Hofs? D,Nordstrand N,Johnson LK,et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention[J]. Eur J Endocrinol,2010,163(5): 735-745.
[12] Spivak H,Abdelmelek MF,Beltran OR,et al. Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States[J] Surg Endosc,2012,26(7): 1909-1919.
[13] Shi X,Karmali S,Sharma AM,et al. A review of laparoscopic sleeve gastrectomy for morbid obesity[J].Obes Surg,2010,20(8): 1171-1177.
[14] Nelson SM,Fleming R. Obesity and reproduction: impact and interventions[J]. Curr Opin Obstet Gynecol,2007,19(4): 384-389.
[15] Gosman GG,King WC,Schrope B,et al. Reproductive health of women electing bariatric surgery[J].Fertil Steril,2010,94(4): 1426-1431.
[16] Jamal M,Gunay Y,Capper A,et al. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis[J]. Surg Obes Relat Dis,2011,8(4): 440-444.
[17] Escobar-Morreale HF,Botella-Carretero JI,Alvarez-Blasco F,et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery[J]. J Clin Endocrinol Metab,2005,90(12): 6364-6369.
[18] Rochester D,Jain A,Polotsky AJ,et al. Partial recovery of luteal function after bariatric surgery in obese women[J]. Fertil Steril,2009,92(4): 1410-1415.
[19] Musella M,Milone M,Bellini M,et al. Effect of bariatric surgery on obesity-related infertility[J]. Surg Obes Relat Dis,2012,8(4): 445-449.
[20] Aricha-Tamir B,Weintraub AY,Levi I,et al. Downsizing pregnancy complications: a study of paired pregnancy outcomes before and after bariatric surgery[J]. Surg Obes Relat Dis,2011,8(4): 434-439.
[21] Fr?hlich G,Pott W,Albayrak ?,et al. Conditions of long-term success in a lifestyle intervention for overweight and obese youths[J]. Pediatrics,2011,128(4): e779-e785.
[22] Martin LF,Finigan KM,Nolan TE. Pregnancy after adjustable gastric banding[J]. Obstet Gynecol,2000,95(6Pt1):927-930.
[23] Burke AE,Bennett WL,Jamshidi RM,et al. Reduced incidence of gestational diabetes with bariatric surgery[J]. Am Coll Surg,2010,211(2): 169-175.
[24] Lesko J,Peaceman A. Pregnancy outcomes in women after bariatric surgery compared with obese and morbidly obese controls[J]. Obstet Gynecol,2012,119(3): 547-554.
[25] Weiss HG,Nehoda H,Labeck B,et al. Pregnancies after adjustable gastric banding[J]. Obes Surg,2001,11(3): 303-306.
[26] Sheiner E,Edri A,Balaban E,et al. Pregnancy outcome of patients who conceive during or after the first year following bariatric surgery[J]. Am J Obstet Gynecol,2011,204(1): 50.e1-50.e6.

相似文献/References:

[1]杨健姝,华飞,唐暎,等.二甲双胍在多囊卵巢综合征患者妊娠期的应用[J].国际内分泌代谢杂志,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
　Yang Jianshu,Hua Fei,Tang Ying,et al.The application of metformin in the pregnant patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(06):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
[2]杨雪,时立新,张巧,等.中老年人群25-羟维生素D3与代谢综合征的 相关性分析[J].国际内分泌代谢杂志,2014,(05):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
　Yang Xue*,Shi Lixin,Zhang Qiao,et al.Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population[J].International Journal of Endocrinology and Metabolism,2014,(06):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(06):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]乔冠华,李强.胰高血糖素样肽-1受体激动剂治疗多囊卵巢综合征的研究进展[J].国际内分泌代谢杂志,2017,37(03):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
　Qiao Guanhua,Li Qiang..Glucagon like peptide-1 receptor agonist in the treatment of polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(06):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
[5]王姝洁,张翼飞,张志国.雷公藤红素在治疗代谢综合征中的作用及相关机制[J].国际内分泌代谢杂志,2017,37(04):258.
　Wang Shujie,Zhang Yifei,Zhang Zhiguo..Effects and related mechanisms of celastrol in the treatment of metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(06):258.
[6]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
　Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(06):270.
[7]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
　Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(06):298.
[8]司马盼盼 孙良阁.多囊卵巢综合征与自身免疫性甲状腺疾病的相关性[J].国际内分泌代谢杂志,2018,38(03):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
　Sima Panpan,Sun Liangge..Correlation between polycystic ovary syndrome and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
[9]谢幸 陈树春 朱海娇 刘阳 王幸.蛙皮素样受体亚型-3与代谢综合征[J].国际内分泌代谢杂志,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
　Xie Xing*,Chen Shuchun,Zhu Haijiao,et al.Bombesin receptor subtype-3 and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(06):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
[10]廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌.多囊卵巢综合征患者血清PTX3、vaspin 水平的观察研究[J].国际内分泌代谢杂志,2018,38(04):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
　Liao Xin*,Zhang Kaiyu,Gao Lin,et al.Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(06):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]

更新日期/Last Update: 2014-12-20